Complementary vascular and matrix regulatory pathways underlie the beneficial mechanism of action of sorafenib in liver fibrosis (Q30465168)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Complementary vascular and matrix regulatory pathways underlie the beneficial mechanism of action of sorafenib in liver fibrosis |
scientific article |
Statements
1 reference
Complementary vascular and matrix regulatory pathways underlie the beneficial mechanism of action of sorafenib in liver fibrosis (English)
1 reference
Gwen Lomberk
1 reference
Dominique Thabut
1 reference
Chittaranjan Routray
1 reference
Uday Shergill
1 reference
Kevin Glaser
1 reference
Robert Huebert
1 reference
Leena Patel
1 reference
Tetyana Masyuk
1 reference
Boris Blechacz
1 reference
Andrew Vercnocke
1 reference
Erik Ritman
1 reference
Richard Ehman
1 reference
Raul Urrutia
1 reference
Vijay Shah
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference